Grand Rounds

Neurology weekly journal

Management of disorders of the nervous system, including the brain and spinal cord.

Latest issue

Jul 4, 2026

Open latest

Browse by publication year

Browse Grand Rounds

Weekly issues

NeurologyLatest first

2026

Feb 14

2026

Grand Rounds issue

High-Impact Updates in MS Diagnosis, Acute Stroke Care, and Neurodegenerative Disease Biomarkers

Performance of the 2024 McDonald Criteria in Patients Under Evaluation for Suspected Multiple Sclerosis.Outcomes of Endovascular Treatment for Acute Basilar Artery Occlusion With National Institutes of Health Stroke Scale Score ≤10.

Open

Jan 24

2026

Grand Rounds issue

Neurology Grand Rounds: Environmental, Vascular, and Biomarker Drivers of Neurologic Risk and Prognosis

Long-Term Exposure to Air Pollution and Risk and Prognosis of Motor Neuron Disease.Clinical Benefit of Thrombectomy in Large-Core Infarction Patients Is Mediated by Malignant Cerebral Edema Reduction.

Open

Jan 17

2026

Grand Rounds issue

Stroke pathways, small-vessel disease, and modifiable brain health risks

Brain-derived tau for monitoring brain injury in acute ischemic stroke.Development of a Prognostic Model for Poststroke Dementia Using Multiple International Cohorts: A STROKOG Collaboration Study.

Open

Jan 10

2026

Grand Rounds issue

Neurology Grand Rounds: Targeted Risk Stratification and Precision Monitoring Across Vascular, Epileptic, and Neurodegenerative Disorders

Early Relapse Risk in Biopsy-Confirmed Primary Central Nervous System Vasculitis.Development and International Validation of a Novel Imaging-Based Risk Score (IsCHEMiA) for the Prediction of Poststroke Epilepsy.

Open

2025

Dec 27

2025

Grand Rounds issue

Imaging, biomarkers, and treatment choices reshaping neurological prognosis and therapy

Time-Dependent Impact of Mismatch Profiles on Outcomes Following Endovascular Thrombectomy for Large Ischemic Stroke.Anticoagulation after Hemorrhagic Transformation in Acute Cardioembolic Ischemic Stroke.

Open

Dec 20

2025

Grand Rounds issue

Biomarkers and trials reshaping care in progressive MS, AD, stroke, ALS, CSVD, and PD

Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial.Prevalence of Alzheimer's disease pathology in the community.

Open

Dec 13

2025

Grand Rounds issue

Emerging neuromodulation, biomarker, and imaging tools for risk stratification across Alzheimer disease, Parkinson disease, and stroke

Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial.Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trials.

Open

Dec 6

2025

Grand Rounds issue

Preclinical AD biomarkers, CSF markers in parkinsonism, and vascular–neurodegenerative interactions

Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline.Plasma Phosphorylated Tau 217 and Amyloid Burden in Older Adults Without Cognitive Impairment: A Meta-Analysis.

Open